Rigel Pharmaceuticals, Inc.【RIGL】 業績推移・財務諸表

機能の使い方
(単位:千ドル) 2Q11 3Q11 4Q11 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25
売上高 - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1,787 4,865 37,857 12,624 10,407 20,857 15,400 55,761 16,021 18,389 18,450 81,018 26,266 21,543 20,409 16,735 29,819 22,410 51,278 26,070 26,886 28,134 35,792 29,534 36,841 55,307 57,596 53,333 101,685 69,462 69,802
売上成長率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 60.9 80.6 176.0 25.6 21.2
売上原価 - - - - - - - - - - - - - - - - - - - - - - - - - - - - 30 69 188 107 311 310 178 155 279 140 321 316 129 151 487 121 1,036 250 342 977 1,075 1,268 3,790 2,025 2,807 8,026 5,789 4,409 4,504 4,753 5,955
研究開発費 17,109 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
販売管理費 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 19,946 18,209 18,121 18,312 18,430 18,920 17,430 21,818 22,121 22,378 22,877 24,515 27,401 26,981 25,897 32,172 27,729 26,306 24,856 26,850 28,449 28,047 27,043 29,520 27,715 29,257 28,936 29,992
営業利益率 (%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - 28.9 23.9 60.1 40.9 33.2
営業利益 -21,557 -18,041 -25,910 -23,310 -24,882 -25,569 -25,616 -25,710 -22,885 -23,930 -16,944 -22,385 -25,456 -21,040 -22,368 -18,241 -13,974 -6,781 -12,747 -17,567 -13,648 -22,739 -15,787 -16,202 -19,344 -17,855 -26,215 -24,734 -26,111 -24,370 2,532 -18,378 -21,339 -12,037 -17,337 21,027 -17,392 -13,781 -18,827 41,755 -13,048 -19,785 -21,418 -26,261 -12,965 -18,403 2,079 -12,725 -5,267 -4,465 1,966 -6,966 447 14,056 16,655 12,773 61,103 28,420 23,170
営業費用 21,952 22,396 25,910 24,060 26,382 25,569 25,616 25,710 24,285 23,930 22,694 22,385 25,456 21,040 30,618 20,419 19,158 19,777 21,284 22,596 22,242 26,499 18,787 19,786 19,344 18,755 26,215 24,734 27,898 29,235 35,325 31,002 31,746 32,894 32,737 34,734 33,413 32,170 37,277 39,263 39,314 41,328 41,827 42,996 42,784 40,813 49,199 38,795 32,153 32,599 33,826 36,500 36,394 41,251 40,941 40,560 40,582 41,042 46,632
経常(税引前)利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 41,271 -14,791 -21,088 -22,701 -27,445 -13,492 -19,037 1,401 - - - - - - - - 11,511 59,982 27,620 22,714
経常(税引前)利益率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 50.9 -56.3 -97.9 -111.2 -164.0 -45.2 -84.9 2.7 - - - - - - - - 21.6 59.0 39.8 32.5
法人税等合計 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1,800 -970 -136 -65 - - - - - - - - - - - - 100 369 -280 -245,351
実効税率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.9 0.6 -1.0 -1080.2
純利益 -21,474 - - - - - - - - - - - - - - - - - - - - - - - - -17,660 -25,871 -24,385 -25,557 -23,766 3,228 -17,598 -20,606 -11,490 -17,200 21,243 -17,576 -14,174 -19,237 39,500 -13,821 -20,952 -22,641 -27,445 -13,492 -19,037 1,401 -13,536 -6,600 -5,692 737 -8,247 -1,030 12,421 14,341 11,446 59,613 27,900 268,065
純利益率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - 24.9 21.5 58.6 40.2 384.0
一株あたり利益 -0.37 -0.25 -0.37 - -0.35 -0.36 -0.29 - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.13 - - - 0.23 -0.08 -0.12 -0.14 -0.16 -0.08 -0.11 0.01 -0.08 -0.04 -0.03 0.01 -0.05 -0.06 0.71 0.81 0.64 3.33 1.55 14.88
希薄化後一株あたり利益 -0.37 -0.25 -0.37 - -0.35 -0.36 -0.29 - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.13 - - - 0.22 -0.08 -0.12 -0.14 -0.16 -0.08 -0.11 0.01 -0.08 -0.04 -0.03 0.01 -0.05 -0.06 0.7 0.81 0.63 3.28 1.46 14.1
EBITDA - 17,259 13,377 61,710 29,023 23,771
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - 30.0 25.1 60.7 41.8 34.1